Cardiovascular Imaging Research Lab
Recent Publications
- Ming Z, et al. ECG-free cine MRI with data-driven clustering of cardiac motion for quantification of ventricular function. NMR in Biomedicine 2024.
- Chang G, et al. Ferumoxytol-Enhanced Cardiac Cine MRI Reconstruction Using a Variable-Splitting Spatiotemporal Network. JMRI 2024
- Ming Z, et al. Dynamic Regularized Adaptive Cluster Optimization (DRACO) for Quantitative Cardiac Cine MRI in Complex Arrhythmias. JMRI 2024
- Sharma S, et al. Plasma FGF23 is associated with left atrial remodeling in children on hemodialysis. Pediatric Nephrology 2023
- Colbert CM, et al. Comparison of Three USPIOs for MRI at 3.0T. JMRI 2022
- Yoshida T, et al. Ferumoxytol-enhanced 4D multiphase, steady-state imaging with magnetic resonance in congenital heart disease: ventricular volume and function across 2D and 3D software platforms. QIMS 2022
- Gao C, et al. Undersampling artifact reduction for free-breathing 3D stack-of-radial MRI based on a deep adversarial learning network. Magnetic Resonance Imaging 2022
- Shahrouki P, et al. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol. Pediatric Radiology 2022
- Hazany S, et al. Regional cerebral small vessel disease (rSCVD) score: a clinical MRI grading system validated in a stroke cohort. Journal of Clinical Neuroscience 2022.
- Berg CJ, et al. Left atrial mechanics and diastolic function among people living with human immunodeficiency virus (from the Veterans Aging Cohort Study). American Journal of Cardiology 2022.
- Colbert CM, et al. Fractional myocardial blood volume by ferumoxytol-enhanced MRI: estimation of ischemic burden. Magnetic Resonance in Medicine 2022.
Upcoming Conferences
You can see our work at:
- ISMRM 2025, Honolulu, Hawai'i
- SCMR 2025, Washington DC
- SMRA 2024, Santiago, Chile
- SCMR 2024, London, United Kingdom
- ISMRM 2024, Suntec, Singapore
- SB3C 2024, Lake Geneva, Wisconsin
FeraSafe Registry
FeraSafe is a multi-center safety registry designed to promote the safe and appropriate use of ferumoxytol for MR imaging applications. FeraSafe aims to facilitate collaborations among institutions exploring the theranostic use of ferumoxytol. FeraSafe is developed and maintained by UCLA investigators.